216 related articles for article (PubMed ID: 29794138)
1. Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells.
Bhattacharyya S; Feferman L; Han X; Ouyang Y; Zhang F; Linhardt RJ; Tobacman JK
J Biol Chem; 2018 Jul; 293(28):11076-11087. PubMed ID: 29794138
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity and Leads to Transcriptional Effects through Sustained Phosphorylation of Transcription Factor MITF.
Bhattacharyya S; Feferman L; Tobacman JK
PLoS One; 2016; 11(4):e0153463. PubMed ID: 27078017
[TBL] [Abstract][Full Text] [Related]
3. Decline in arylsulfatase B leads to increased invasiveness of melanoma cells.
Bhattacharyya S; Feferman L; Terai K; Dudek AZ; Tobacman JK
Oncotarget; 2017 Jan; 8(3):4169-4180. PubMed ID: 27926479
[TBL] [Abstract][Full Text] [Related]
4. Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects.
Bhattacharyya S; Feferman L; Tobacman JK
Oncogene; 2014 Nov; 33(47):5467-76. PubMed ID: 24240681
[TBL] [Abstract][Full Text] [Related]
5. Regulation of chondroitin-4-sulfotransferase (CHST11) expression by opposing effects of arylsulfatase B on BMP4 and Wnt9A.
Bhattacharyya S; Feferman L; Tobacman JK
Biochim Biophys Acta; 2015 Mar; 1849(3):342-52. PubMed ID: 25511584
[TBL] [Abstract][Full Text] [Related]
6. Arylsulfatase B (N-acetylgalactosamine-4-sulfatase): potential role as a biomarker in prostate cancer.
Feferman L; Bhattacharyya S; Deaton R; Gann P; Guzman G; Kajdacsy-Balla A; Tobacman JK
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):277-84. PubMed ID: 23835622
[TBL] [Abstract][Full Text] [Related]
7. Exogenous recombinant N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) inhibits progression of B16F10 cutaneous melanomas and modulates cell signaling.
Bhattacharyya S; O-Sullivan I; Tu J; Chen Z; Tobacman JK
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166913. PubMed ID: 37813168
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3.
Bhattacharyya S; Feferman L; Tobacman JK
J Biol Chem; 2014 Jun; 289(25):17564-75. PubMed ID: 24778176
[TBL] [Abstract][Full Text] [Related]
9. Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin.
Kotlo K; Bhattacharyya S; Yang B; Feferman L; Tejaskumar S; Linhardt R; Danziger R; Tobacman JK
Glycoconj J; 2013 Oct; 30(7):667-76. PubMed ID: 23385884
[TBL] [Abstract][Full Text] [Related]
10. Increased CHST15 follows decline in arylsulfatase B (ARSB) and disinhibition of non-canonical WNT signaling: potential impact on epithelial and mesenchymal identity.
Bhattacharyya S; Feferman L; Han X; Xia K; Zhang F; Linhardt RJ; Tobacman JK
Oncotarget; 2020 Jun; 11(24):2327-2344. PubMed ID: 32595831
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of estrogen exposure on arylsulfatase B, galactose-6-sulfatase, and steroid sulfatase in rat prostate development.
Feferman L; Bhattacharyya S; Birch L; Prins GS; Tobacman JK
J Steroid Biochem Mol Biol; 2014 Sep; 143():105-14. PubMed ID: 24508597
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia.
Bhattacharyya S; Tobacman JK
PLoS One; 2012; 7(3):e33250. PubMed ID: 22428001
[TBL] [Abstract][Full Text] [Related]
13. Molecular signature of kappa-carrageenan mimics chondroitin-4-sulfate and dermatan sulfate and enables interaction with arylsulfatase B.
Bhattacharyya S; Tobacman JK
J Nutr Biochem; 2012 Sep; 23(9):1058-63. PubMed ID: 22079206
[TBL] [Abstract][Full Text] [Related]
14. Dihydrotestosterone inhibits arylsulfatase B and Dickkopf Wnt signaling pathway inhibitor (DKK)-3 leading to enhanced Wnt signaling in prostate epithelium in response to stromal Wnt3A.
Bhattacharyya S; Feferman L; Tobacman JK
Prostate; 2019 May; 79(7):689-700. PubMed ID: 30801800
[TBL] [Abstract][Full Text] [Related]
15. Decline in arylsulfatase B and Increase in chondroitin 4-sulfotransferase combine to increase chondroitin 4-sulfate in traumatic brain injury.
Bhattacharyya S; Zhang X; Feferman L; Johnson D; Tortella FC; Guizzetti M; Tobacman JK
J Neurochem; 2015 Aug; 134(4):728-39. PubMed ID: 25943740
[TBL] [Abstract][Full Text] [Related]
16. Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3).
Bhattacharyya S; Feferman L; Tobacman JK
Oncotarget; 2017 Nov; 8(59):100242-100260. PubMed ID: 29245974
[TBL] [Abstract][Full Text] [Related]
17. Profound Impact of Decline in N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on Molecular Pathophysiology and Human Diseases.
Tobacman JK; Bhattacharyya S
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361933
[TBL] [Abstract][Full Text] [Related]
18. Arylsulfatase B regulates interaction of chondroitin-4-sulfate and kininogen in renal epithelial cells.
Bhattacharyya S; Kotlo K; Danziger R; Tobacman JK
Biochim Biophys Acta; 2010 May; 1802(5):472-7. PubMed ID: 20152898
[TBL] [Abstract][Full Text] [Related]
19. Arylsulfatase B is reduced in prostate cancer recurrences.
Feferman L; Deaton R; Bhattacharyya S; Xie H; Gann PH; Melamed J; Tobacman JK
Cancer Biomark; 2017 Dec; 21(1):229-234. PubMed ID: 29081414
[TBL] [Abstract][Full Text] [Related]
20. Arylsulfatase B modulates neurite outgrowth via astrocyte chondroitin-4-sulfate: dysregulation by ethanol.
Zhang X; Bhattacharyya S; Kusumo H; Goodlett CR; Tobacman JK; Guizzetti M
Glia; 2014 Feb; 62(2):259-71. PubMed ID: 24311516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
